Journal article
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial
- Abstract:
-
Optimal red cell transfusion support in myelodysplastic syndromes (MDS) has not been tested and established. The aim of this study was to demonstrate feasibility of recruitment and follow‐up in an outpatient setting with an exploratory assessment of quality of life (QoL) outcomes (EORTC QLQ‐C30 and EQ‐5D‐5L). We randomised MDS patients to standardised transfusion algorithms comparing current restrictive transfusion thresholds (80 g/l, to maintain haemoglobin 85–100 g/l) with liberal threshold...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Australian and New Zealand Society of Blood Transfusion (ANZSBT)
More from this funder
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- British Journal of Haematology Journal website
- Volume:
- 189
- Issue:
- 2
- Pages:
- 279-290
- Publication date:
- 2020-01-20
- Acceptance date:
- 2019-10-06
- DOI:
- EISSN:
-
1365-2141
- ISSN:
-
0007-1048
- Pmid:
-
31960409
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1084451
- Local pid:
- pubs:1084451
- Deposit date:
- 2020-06-02
Terms of use
- Copyright holder:
- British Society for Haematology and John Wiley & Sons Ltd
- Copyright date:
- 2020
- Rights statement:
- © 2020 British Society for Haematology and John Wiley & Sons Ltd.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Wiley at: https://doi.org/10.1111/bjh.16347
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record